AGUGGINI, SERGIO
AGUGGINI, SERGIO
Dipartimento di Specialità Medico-Chirurgiche, Scienze Radiologiche e Sanità Pubblica
Accuracy of mammography and echography versus clinical palpation in the assessment of response to primary chemotherapy in breast cancer patients with operable disease
2001-01-01 Fiorentino, C.; Berruti, A.; Bottini, A.; Bodini, M.; Brizzi, M. P.; Brunelli, A.; Marini, U.; Allevi, G.; Aguggini, S.; Tira, A.; Alquati, P.; Olivetti, L.; Dogliotti, L.
Anti-Angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients
2010-01-01 Mele, Teresa; Generali, Daniele; Fox, Stephen; Brizzi, Maria Pia; Bersiga, Alessandra; Milani, Manuela; Allevi, Giovanni; Bonardi, Simone; Aguggini, Sergio; Volante, Marco; Dogliotti, Luigi; Bottini, Alberto; Harris, Adrian; Berruti, Alfredo
Effect of primary letrozole treatment on tumor expression of mTOR and HIF-1α and relation to clinical response
2015-01-01 Generali, Daniele; Berruti, Alfredo; Cappelletti, Maria Rosa; Zanotti, Laura; Brugnoli, Giulia; Forti, Michela; Bedussi, Francesca; Vailati, Maria Elena; Milani, Manuela; Strina, Carla; Ardine, Mara; Aguggini, Sergio; Allevi, Giovanni; Ferrero, Giuseppina; Bertoni, Ramona; Bottini, Alberto; Harris, Adrian L.; Fox, Stephen B.
Hypoxia-related biological markers as predictors of epirubicinbased treatment responsiveness and resistance in locally advanced breast cancer
2017-01-01 Milani, Manuela; Venturini, Sergio; Bonardi, Simone; Allevi, Giovanni; Strina, Carla; Cappelletti, Maria Rosa; Corona, Silvia Paola; Aguggini, Sergio; Bottini, Alberto; Berruti, Alfredo; Jubb, Adrian; Campo, Leticia; Harris, Adrian L.; Gatter, Kevin; Fox, Stephen B.; Generali, Daniele; Roviello, Giandomenico
Phosphorylated ERα, HIF-1α, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer
2009-01-01 Generali, Daniele; Buffa, Francesca M.; Berruti, Alfredo; Brizzi, Maria P.; Campo, Leticia; Bonardi, Simone; Bersiga, Alessandra; Allevi, Giovanni; Milani, Manuela; Aguggini, Sergio; Papotti, Mauro; Dogliotti, Luigi; Bottini, Alberto; Harris, Adrian L.; Fox, Stephen B.
Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin/tamoxifen therapy for breast cancer
2006-01-01 Generali, D.; Fox, S. B.; Berruti, A.; Brizzi, M. P.; Campo, L.; Bonardi, S.; Wigfield, S. M.; Bruzzi, P.; Bersiga, A.; Allevi, G.; Milani, M.; Aguggini, S.; Dogliotti, L.; Bottini, A.; Harris, A. L.
The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen
2011-01-01 Fox, Stephen B; Generali, Daniele; Berruti, Alfredo; Brizzi, Maria P.; Campo, Leticia; Bonardi, Simone; Bersiga, Alessandra; Allevi, Giovanni; Milani, Manuela; Aguggini, Sergio; Mele, Teresa; Dogliotti, Luigi; Bottini, Alberto; Harris, Adrian L.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Accuracy of mammography and echography versus clinical palpation in the assessment of response to primary chemotherapy in breast cancer patients with operable disease | 1-gen-2001 | Fiorentino, C.; Berruti, A.; Bottini, A.; Bodini, M.; Brizzi, M. P.; Brunelli, A.; Marini, U.; Allevi, G.; Aguggini, S.; Tira, A.; Alquati, P.; Olivetti, L.; Dogliotti, L. | |
| Anti-Angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients | 1-gen-2010 | Mele, Teresa; Generali, Daniele; Fox, Stephen; Brizzi, Maria Pia; Bersiga, Alessandra; Milani, Manuela; Allevi, Giovanni; Bonardi, Simone; Aguggini, Sergio; Volante, Marco; Dogliotti, Luigi; Bottini, Alberto; Harris, Adrian; Berruti, Alfredo | |
| Effect of primary letrozole treatment on tumor expression of mTOR and HIF-1α and relation to clinical response | 1-gen-2015 | Generali, Daniele; Berruti, Alfredo; Cappelletti, Maria Rosa; Zanotti, Laura; Brugnoli, Giulia; Forti, Michela; Bedussi, Francesca; Vailati, Maria Elena; Milani, Manuela; Strina, Carla; Ardine, Mara; Aguggini, Sergio; Allevi, Giovanni; Ferrero, Giuseppina; Bertoni, Ramona; Bottini, Alberto; Harris, Adrian L.; Fox, Stephen B. | |
| Hypoxia-related biological markers as predictors of epirubicinbased treatment responsiveness and resistance in locally advanced breast cancer | 1-gen-2017 | Milani, Manuela; Venturini, Sergio; Bonardi, Simone; Allevi, Giovanni; Strina, Carla; Cappelletti, Maria Rosa; Corona, Silvia Paola; Aguggini, Sergio; Bottini, Alberto; Berruti, Alfredo; Jubb, Adrian; Campo, Leticia; Harris, Adrian L.; Gatter, Kevin; Fox, Stephen B.; Generali, Daniele; Roviello, Giandomenico | |
| Phosphorylated ERα, HIF-1α, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer | 1-gen-2009 | Generali, Daniele; Buffa, Francesca M.; Berruti, Alfredo; Brizzi, Maria P.; Campo, Leticia; Bonardi, Simone; Bersiga, Alessandra; Allevi, Giovanni; Milani, Manuela; Aguggini, Sergio; Papotti, Mauro; Dogliotti, Luigi; Bottini, Alberto; Harris, Adrian L.; Fox, Stephen B. | |
| Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin/tamoxifen therapy for breast cancer | 1-gen-2006 | Generali, D.; Fox, S. B.; Berruti, A.; Brizzi, M. P.; Campo, L.; Bonardi, S.; Wigfield, S. M.; Bruzzi, P.; Bersiga, A.; Allevi, G.; Milani, M.; Aguggini, S.; Dogliotti, L.; Bottini, A.; Harris, A. L. | |
| The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen | 1-gen-2011 | Fox, Stephen B; Generali, Daniele; Berruti, Alfredo; Brizzi, Maria P.; Campo, Leticia; Bonardi, Simone; Bersiga, Alessandra; Allevi, Giovanni; Milani, Manuela; Aguggini, Sergio; Mele, Teresa; Dogliotti, Luigi; Bottini, Alberto; Harris, Adrian L. |